176 related articles for article (PubMed ID: 28818640)
1. The influence of physical activity in the anti-tumor immune response in experimental breast tumor.
Bianco TM; Abdalla DR; Desidério CS; Thys S; Simoens C; Bogers JP; Murta EFC; Michelin MA
Immunol Lett; 2017 Oct; 190():148-158. PubMed ID: 28818640
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
3. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
4. Spleen-derived dendritic cells engineered to enhance interleukin-12 production elicit therapeutic antitumor immune responses.
Furumoto K; Arii S; Yamasaki S; Mizumoto M; Mori A; Inoue N; Isobe N; Imamura M
Int J Cancer; 2000 Sep; 87(5):665-72. PubMed ID: 10925360
[TBL] [Abstract][Full Text] [Related]
5. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
[TBL] [Abstract][Full Text] [Related]
6. Selective depletion of CD11c
Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
[TBL] [Abstract][Full Text] [Related]
7. Type 1 and type 2 tumor infiltrating effector cell subpopulations in progressive breast cancer.
Reome JB; Hylind JC; Dutton RW; Dobrzanski MJ
Clin Immunol; 2004 Apr; 111(1):69-81. PubMed ID: 15093554
[TBL] [Abstract][Full Text] [Related]
8. Effect of porcine circovirus type 2 (PCV2) on the function of splenic CD11c
Wang X; Chen L; Yuan W; Li Y; Li L; Li T; Li H; Song Q
Arch Virol; 2017 May; 162(5):1289-1298. PubMed ID: 28138774
[TBL] [Abstract][Full Text] [Related]
9. Effects of histamine and its antagonists on murine T-cells and bone marrow-derived dendritic cells.
Hu X; Zafar MI; Gao F
Drug Des Devel Ther; 2015; 9():4847-60. PubMed ID: 26346531
[TBL] [Abstract][Full Text] [Related]
10. Silencing SOCS1 in dendritic cells promote survival of mice with systemic Candida albicans infection via inducing Th1-cell differentiation.
Shi D; Li D; Wang Q; Kong X; Mei H; Shen Y; Liu W
Immunol Lett; 2018 May; 197():53-62. PubMed ID: 29581081
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived dendritic cells under influence of experimental breast cancer and physical activity.
Abdalla DR; Gomes BBM; Murta EFC; Michelin MA
Oncol Lett; 2017 Mar; 13(3):1406-1410. PubMed ID: 28454269
[TBL] [Abstract][Full Text] [Related]
12. [Effect of neonatal BCG vaccination on phenotype and function of splenic dendritic cells of BALB/c mice].
Liu CH; Liu EM; Liu CH; Liu W; Yang XQ; Li X
Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):784-8. PubMed ID: 19099886
[TBL] [Abstract][Full Text] [Related]
13. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic Dendritic Cell Vaccination in Experimental Breast Cancer Controls Immunity and Hepatic Metastases.
Vieira JF; Peixoto AP; Murta EFC; Michelin MA
Anticancer Res; 2021 Jul; 41(7):3419-3427. PubMed ID: 34230137
[TBL] [Abstract][Full Text] [Related]
15. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients].
Han CH; Li HF; Wang YX; Zhang M; Wang Y; Yin M; Min ZL; Zheng KL
Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1327-32. PubMed ID: 16029632
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity.
Tatsumi T; Huang J; Gooding WE; Gambotto A; Robbins PD; Vujanovic NL; Alber SM; Watkins SC; Okada H; Storkus WJ
Cancer Res; 2003 Oct; 63(19):6378-86. PubMed ID: 14559827
[TBL] [Abstract][Full Text] [Related]
17. Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.
Shi D; Li D; Yin Q; Qiu Y; Yan H; Shen Y; Lu G; Liu W
Immunol Res; 2015 Mar; 61(3):206-18. PubMed ID: 25381480
[TBL] [Abstract][Full Text] [Related]
18. CD40 engagement strongly induces CD25 expression on porcine dendritic cells and polarizes the T cell immune response toward Th1.
Pilon C; Levast B; Meurens F; Le Vern Y; Kerboeuf D; Salmon H; Velge-Roussel F; Lebranchu Y; Baron C
Mol Immunol; 2009 Jan; 46(3):437-47. PubMed ID: 19036453
[TBL] [Abstract][Full Text] [Related]
19. The influence of physical activity on the profile of immune response cells and cytokine synthesis in mice with experimental breast tumors induced by 7,12-dimethylbenzanthracene.
Abdalla DR; Murta EF; Michelin MA
Eur J Cancer Prev; 2013 May; 22(3):251-8. PubMed ID: 22976388
[TBL] [Abstract][Full Text] [Related]
20. Lead effects on development and function of bone marrow-derived dendritic cells promote Th2 immune responses.
Gao D; Mondal TK; Lawrence DA
Toxicol Appl Pharmacol; 2007 Jul; 222(1):69-79. PubMed ID: 17512567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
